heart failure
Emory U Enrolling Heart Failure Patients into BioCardia's Follow-up CardiAMP Cell Therapy Trial
After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.
Researchers shared data at ACC from BioCardia's initial Phase III cell therapy trial, which the firm stopped enrolling based on interim data.
Spotlight on Lp(a) Risks, Low Testing Prevalence, and Potential Treatments at Cardiology Meeting
Premium
At ACC's annual meeting, there was a big focus on educating doctors about Lp(a) testing and its role in heart disease as new drugs advance in clinical trials.
University of Colorado Anschutz Prepping for Three Cardiomyopathy Gene Therapy Trials This Year
Premium
Investigators will use a research registry at the university to recruit patients with various heart disorders and certain genetic features into the trials.
Bayer's AskBio Enrolls First Patient in Phase II Gene Therapy Trial for Heart Failure
Congestive heart failure patients enrolled in the trial will receive either a high or low dose of the gene therapy AB-1002 or a placebo.